Drug Pipeline & Clinical Trials at AAAP 37th Annual Meeting and Scientific Symposium
7 sessions on drug pipeline & clinical trials · November 12–15, 2026, Memphis, TN. Compare drug pipeline & clinical trials at other meetings →
Friday, November 13
09:00–10:40 · Symposium
Symposium II - Neuromodulation to Treat Addictions: What’s Available and What’s in the Pipeline
Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey
Examines current and emerging neuromodulation approaches such as rTMS and focused ultrasound for treating substance use disorders, including personalization and response monitoring.
15:30–17:00 · Oral abstract
Absolute and Relative Responses of Pharmacological Treatments for Gambling Disorder: A Systematic Review and Meta-Analysis
Meta-analysis of absolute and relative treatment responses to medications for gambling disorder.
Saturday, November 14
08:45–10:25 · Symposium
Symposium III - Beyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Discusses moving cannabis use disorder trials and clinical care from abstinence-only endpoints toward reduction-based, patient-centered outcome measures.
Sunday, November 15
Posters (2)
- Expanding the Therapeutic Landscape of Alcohol Use Disorder: Brenipatide (Dual GIP/GLP-1 Receptor Agonist) Clinical Trials — Marc Fishman
- Incidence of Precipitated Withdrawal Following Rapid Initiation of Weekly and Monthly Extended-Release Injectable Buprenorphine in Adults With Moderate-to-Severe Opioid Use Disorder Not Currently Receiving Buprenorphine: A Study Protocol — Natalie Budilovsky-Kelley
Schedule to be announced
Symposium · Symposia
Beyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Argues for moving beyond abstinence as the sole endpoint in cannabis use disorder trials, discussing reduction-based and patient-centered outcome measures.
Symposium · Symposia
Neuromodulation to Treat Addictions: What's Available and What's in the Pipeline
Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey
Reviews current and investigational neuromodulation techniques for substance use disorders, including rTMS and focused ultrasound.
Other topics at this meeting
Substance Use Disorders 87Opioid Use Disorder 48Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Emergency & Acute Psychiatry 11Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8